NCT01873378View on ClinicalTrials.gov

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Uterine Myoma
Interventions
DRUG

Triptorelin 3.75 mg

Trial Locations (1)

00191

Arbor Vitae Endoscopic Centre, Rome

All Listed Sponsors
lead

Azienda Ospedaliera S. Maria della Misericordia

OTHER

NCT01873378 - GnRH Agonist Pretreatment in Hysteroscopic Myomectomy | Biotech Hunter | Biotech Hunter